Patient Groups Are Focus of New Alliances In a Shift of Cancer Advocacy Agenda
In Brief: US Pharmacopeia Names Advisory Panel For Hematologic And Oncological Disease
Two Groups Form to Mark Cancer Act’s 25th Anniversary
M.D. Anderson Must Evaluate 8 Patients In Controversial Study
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field
- KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants









